Meyahealth
HomeGeneticsGeneTGFB2 gene
Back to Gene
TGFB2 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

TGFB2 gene

The TGFB2 gene is responsible for producing the TGFβ-2 protein, a key regulator of cellular development and connective tissue integrity throughout the body.

Normal Function

The TGFB2 gene provides instructions for producing a protein called transforming growth factor beta-2 (TGFβ-2). This protein is required for development before birth and throughout life. By binding to receptor proteins on the surface of cells, TGFβ-2 triggers signaling pathways that control cell proliferation, differentiation, motility, and apoptosis. Because it prevents cells from growing or dividing in an uncontrolled way, it can suppress the formation of tumors.

TGFβ-2 is involved in the formation of blood vessels, regulation of muscle tissue and body fat, wound healing, and immune system function. It is especially abundant in skeletal tissues, where it regulates bone growth, and in the extracellular matrix.

Health Conditions Related to Genetic Changes

Loeys-Dietz syndrome

At least 20 mutations in the TGFB2 gene have been found to cause Loeys-Dietz syndrome type IV, a disorder affecting connective tissue that provides structure to blood vessels, the skeleton, and other body parts. This condition is characterized by blood vessel abnormalities, heart defects, and skeletal deformities.

  • Mutations lead to the production of a TGFβ-2 protein with little or no function, preventing it from binding to its receptors.
  • Paradoxically, TGF-β pathway signaling occurs at a greater intensity than normal, likely due to compensatory activity by other proteins in the pathway.
  • This overactive signaling disrupts the development of connective tissue.
  • Some individuals have deletions of the entire TGFB2 gene, which may also result in intellectual disability and movement problems.

Frequently Asked Questions

The primary risk is the development of aneurysms (bulges) in the aorta and other arteries, which can dissect (tear) or rupture, leading to life-threatening internal bleeding. These are monitored through regular imaging scans (MRI, CT, echocardiography) to track aneurysm size and growth. Prompt surgical intervention is crucial if aneurysms reach a critical size or show signs of rapid expansion.
Early warning signs can include a wide range of features such as a broad or bifid uvula (split at the tip), widely spaced eyes (hypertelorism), a bluish tint to the whites of the eyes (blue sclera), and easily bruised skin. More serious signs involve cardiovascular issues like an enlarged aorta (aneurysm) or heart defects, which may be detected during prenatal or newborn screenings.
Yes, Loeys-Dietz syndrome type IV is inherited in an autosomal dominant pattern. This means an affected individual has a 50% chance of passing the TGFB2 mutation to each child. Family members of an affected individual, even if asymptomatic, should be screened for the condition, especially for aortic abnormalities. Genetic counseling is highly recommended for family planning and risk assessment.
Diagnosis typically involves a combination of clinical evaluation for characteristic features, imaging studies (like echocardiograms and MRI/CT scans) to assess the aorta and other blood vessels, and genetic testing to confirm a TGFB2 gene mutation. Management includes regular cardiovascular monitoring, medications to reduce aortic stress (e.g., beta-blockers, ARBs), and surgical repair of aortic aneurysms when they reach a certain size. Skeletal issues may require orthopedic interventions.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ